We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA will revise the warning portion of birth control patch Ortho Evra’s label to incorporate two epidemiology studies sponsored by Johnson & Johnson (J&J), the agency announced Sept. 20.